Preferred Label : eslicarbazepine acetate;

MeSH note : a voltage-gated sodium channel blocker;

CISMeF synonym : BIA 2-093; aptiom; Zebinix;

MeSH synonym : 10-acetoxy-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide;

MeSH hyponym : BIA-2-093;

Is substance : O;

UNII : BEA68ZVB2K;

InChIKey : QIALRBLEEWJACW-INIZCTEOSA-N;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD008907/EPILEPSY_ajout-dacetate-deslicarbazepine-dans-lepilepsie-focale-resistante-aux-medicaments
2021
false
true
false
United Kingdom
France
Refractory epilepsy (disorder)
dibenzazepines
Drug Resistant Epilepsy
treatment outcome
review of literature
french abstract
eslicarbazepine acetate
epilepsies, partial

---
https://www.has-sante.fr/portail/jcms/c_2875359/fr/zebinix
2018
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
adult
epilepsies, partial
eslicarbazepine acetate
anticonvulsants
eslicarbazepine
evaluation of the transparency committee
Zebinix
dibenzazepines

---
Maintien du remboursement dans les mêmes conditions
http://www.has-sante.fr/portail/jcms/c_2749829/fr/zebinix
2017
false
France
French
English
eslicarbazepine acetate
administration, oral
dibenzazepines
eslicarbazepine
insurance, health, reimbursement
drug therapy, combination
adult
epilepsies, partial
treatment outcome
eslicarbazepine acetate
dibenzazepines
evaluation of the transparency committee

---
Summary Basis of Decision (SBD) for Aptiom
Eslicarbazepine acetate, 200 mg, 400 mg, 600 mg, and 800 mg, tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00271
2014
false
false
false
Canada
French
English
drug approval
canada
eslicarbazepine acetate
eslicarbazepine acetate
eslicarbazepine
epilepsies, partial
administration, oral
drug evaluation
risk assessment
treatment outcome
Voltage-Gated sodium channel blockers
Voltage-Gated sodium channel blockers
clinical trials, phase iii as topic
drug information
Product containing eslicarbazepine in oral dose form (medicinal product form)
dibenzazepines
dibenzazepines

---
https://www.ema.europa.eu/medicines/human/EPAR/Exalief
2012
United Kingdom
English
French
syndication feed
drug therapy, combination
eslicarbazepine acetate
eslicarbazepine acetate
dibenzazepines
dibenzazepines
tablets
administration, oral
drug approval
drug labeling
treatment outcome
adult
anticonvulsants
aged
drug interactions
pregnancy
breast feeding
anticonvulsants
drug evaluation, preclinical
eslicarbazepine
dibenzazepines
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Zebinix
2012
United Kingdom
English
French
syndication feed
aged
eslicarbazepine acetate
eslicarbazepine acetate
anticonvulsants
anticonvulsants
dibenzazepines
dibenzazepines
drug approval
drug labeling
treatment outcome
tablets
administration, oral
drug interactions
breast feeding
pregnancy
drug therapy, combination
adult
eslicarbazepine
epilepsies, partial
drug evaluation
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68829121
2012
France
summary of product characteristics
package leaflet
tablets
acetates
eslicarbazepine acetate

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/zebinix_-_ct-8152.pdf
http://www.has-sante.fr/portail/jcms/c_1014503/zebinix-eslicarbazepine-anti-epileptique
http://www.has-sante.fr/portail/jcms/c_991889/zebinix
2010
false
France
French
administration, oral
eslicarbazepine
eslicarbazepine acetate
dibenzazepines
insurance, health, reimbursement
drug therapy, combination
adult
epilepsies, partial
aged
treatment outcome
eslicarbazepine acetate
dibenzazepines
anticonvulsants
anticonvulsants
dibenzazepines
guidelines for drug use
evaluation of the transparency committee

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.